Fredun Pharma

{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,374.95",
    "chg": 10.75,
    "chgp": "0.45%",
    "dir": 1,
    "prev_price": "2,364.20",
    "mcapval": "1,235.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE194R01017",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "21.54 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Fredun Pharmaceuticals Declines 2.10% Despite Multiple All-Time Highs: 5 Key Factors Behind the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-declines-210-despite-multiple-all-time-highs-5-key-factors-behind-the-weeks-volatility-3983207",
        "imagepath": "",
        "date": "2026-05-09 13:09:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> New 52-week and all-time high at Rs.2,424</p>\n                    <p><strong>5 May:</strong> Further 52-week and all-time high at Rs.2,471</p>\n                    <p><strong>6 May:</strong> New 52-week and all-time high at Rs.2,548</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.2,374.95 (-2.10%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,426.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,374.95</div><div class=\"stat-change negative..."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fredun-pharmaceuticals-ltd-is-rated-buy-3977474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_mojoScore_3977474.png",
        "date": "2026-05-06 10:11:00",
        "description": "Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2548",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2548-3977340",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_3977340.png",
        "date": "2026-05-06 09:48:44",
        "description": "Surging to a new all-time high of Rs 2,548 on 6 May 2026, Fredun Pharmaceuticals Ltd has demonstrated remarkable price momentum, extending gains over four consecutive sessions to deliver a near 20% rally. This milestone caps a spectacular 257.45% return over the past year, vastly outperforming the Sensex’s decline of 4.16% during the same period."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,548 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-at-rs-2548-3977279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_3977279.png",
        "date": "2026-05-06 09:35:29",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2471",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2471-3975487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_3975487.png",
        "date": "2026-05-05 09:47:32",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd has reached a new 52-week high of Rs 2471 on 05 May 2026, marking a remarkable rally of 242.02% over the past year. This milestone is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader market trades cautiously."
      },
      {
        "title": "Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,471 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-all-time-high-at-rs2471-mark-3975421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_3975421.png",
        "date": "2026-05-05 09:33:36",
        "description": ""
      },
      {
        "title": "Fredun Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-change-amid-strong-returns-3974662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_valuationdot_3974662.png",
        "date": "2026-05-05 08:01:22",
        "description": "Fredun Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting a significant change in price attractiveness. Despite this, the company’s robust financial metrics and strong market performance continue to underpin its Buy rating, signalling confidence in its growth prospects within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "244.83% Stock Return, 81.2% Profit Growth: What's Driving Fredun Pharmaceuticals Ltd's Multibagger Rerating?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-emerges-as-a-multibagger-with-2448-returns-in-one-year-3974220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_multibagger_3974220.png",
        "date": "2026-05-04 15:15:04",
        "description": "A 244.83% stock return in one year. An 81.2% growth in net profit over the same period. The gap between those two numbers — roughly 163 percentage points — is driven largely by the market's willingness to pay more for each rupee of Fredun Pharmaceuticals Ltd's earnings. That premium expansion is the defining feature of this multibagger rally."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2424",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fredun-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2424-3973844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FredunPharmaceu_priceRelatedfactors_3973844.png",
        "date": "2026-05-04 10:36:03",
        "description": "Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a new 52-week high of Rs 2424 on 04 May 2026, marking a remarkable rally from its low of Rs 666 just a year ago. This milestone underscores a powerful momentum driven by a confluence of technical indicators aligning in favour of the stock’s upward trajectory."
      }
    ],
    "total": 260,
    "sid": "1002605",
    "stock_news_url": "https://www.marketsmojo.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "29-Apr-2026",
      "details": "Please find enclosed press release titled Fredun Pharmaceuticals Expands Manufacturing Base with Fifty Facility at Palghar issued by Fredun Pharmaceuticals Limited.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "28-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Fredun Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1987PLC043662</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>216.43</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Vaishnavi Sahu <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@fredungroup.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Fredun Nariman Medhora <br/> Designation: Managing Director and CFO <br/> EmailId: business@fredungroup.com</div> </div> <div> <br/> Date: 28/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "15-Apr-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Fredun Nariman Medhora & Others",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Sep 25",
          "dt": "2025-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Fredun Pharmaceuticals Declines 2.10% Despite Multiple All-Time Highs: 5 Key Factors Behind the Week’s Volatility

2026-05-09 13:09:11

Key Events This Week

4 May: New 52-week and all-time high at Rs.2,424

5 May: Further 52-week and all-time high at Rs.2,471

6 May: New 52-week and all-time high at Rs.2,548

8 May: Week closes at Rs.2,374.95 (-2.10%)

Week Open

Rs.2,426.00

Week Close

Rs.2,374.95

Read full news article

Fredun Pharmaceuticals Ltd is Rated Buy

2026-05-06 10:11:00

Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2548

2026-05-06 09:48:44

Surging to a new all-time high of Rs 2,548 on 6 May 2026, Fredun Pharmaceuticals Ltd has demonstrated remarkable price momentum, extending gains over four consecutive sessions to deliver a near 20% rally. This milestone caps a spectacular 257.45% return over the past year, vastly outperforming the Sensex’s decline of 4.16% during the same period.

Read full news article

Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,548 as Momentum Builds Across Timeframes

2026-05-06 09:35:29

Read full news article

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2471

2026-05-05 09:47:32

Surging past its previous peaks, Fredun Pharmaceuticals Ltd has reached a new 52-week high of Rs 2471 on 05 May 2026, marking a remarkable rally of 242.02% over the past year. This milestone is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader market trades cautiously.

Read full news article

Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,471 as Momentum Builds Across Timeframes

2026-05-05 09:33:36

Read full news article

Fredun Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change Amid Strong Returns

2026-05-05 08:01:22

Fredun Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting a significant change in price attractiveness. Despite this, the company’s robust financial metrics and strong market performance continue to underpin its Buy rating, signalling confidence in its growth prospects within the Pharmaceuticals & Biotechnology sector.

Read full news article

244.83% Stock Return, 81.2% Profit Growth: What's Driving Fredun Pharmaceuticals Ltd's Multibagger Rerating?

2026-05-04 15:15:04

A 244.83% stock return in one year. An 81.2% growth in net profit over the same period. The gap between those two numbers — roughly 163 percentage points — is driven largely by the market's willingness to pay more for each rupee of Fredun Pharmaceuticals Ltd's earnings. That premium expansion is the defining feature of this multibagger rally.

Read full news article

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2424

2026-05-04 10:36:03

Surging past its previous peaks, Fredun Pharmaceuticals Ltd touched a new 52-week high of Rs 2424 on 04 May 2026, marking a remarkable rally from its low of Rs 666 just a year ago. This milestone underscores a powerful momentum driven by a confluence of technical indicators aligning in favour of the stock’s upward trajectory.

Read full news article

View All News